Telatinib mesylate

Telatinib mesylate Suppliers list
Company Name: ChengDu TongChuangYuan Pharmaceutical Co.Ltd  
Tel: 28-83379370 13880556291
Email: tcy@tcypharm.com
Company Name: ChengDu TongChuangYuan Pharmaceutical Co.Ltd  
Tel: 028-83379370 13880556291
Email: tcy@tcypharm.com
Company Name: Kaixin Chemical (Hong Kong) Limited  
Tel: 010-88886666-01 13112345678
Email: loyson@qq.com
Company Name: InvivoChem  
Tel: 13549236410
Email: sales@invivochem.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com

Telatinib mesylate manufacturers

Telatinib mesylate Basic information
Product Name:Telatinib mesylate
Synonyms:Telatinib mesylate;4-(((4-((4-chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide methanesulfonate;Telatinib mesylate (Bay 57-9352 mesylate)
CAS:332013-26-0
MF:C21H20ClN5O6S
MW:505.93
EINECS:
Product Categories:
Mol File:332013-26-0.mol
Telatinib mesylate Structure
Telatinib mesylate Chemical Properties
form Solid
color White to off-white
Safety Information
MSDS Information
Telatinib mesylate Usage And Synthesis
UsesTelatinib mesylate (Bay 57-9352 mesylate) is a potent and orally active VEGFR2, VEGFR3, PDGFα, and c-Kit inhibitor with IC50s of 6 nM, 4 nM, 15 nM and 1 nM, respectively[1].
in vivo

Telatinib (15 mg/kg; oral dministration; every 2nd and 3rd day; total 12 times; male athymic NCR (nu/nu) nude mice) with Doxorubicin (1.8 mg/kg) significantly decreases the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model[2].

Animal Model:Male athymic NCR (nu/nu) nude mice (13-15 g, age 4-5 weeks) injected with H460 and H460/MX20 cells[2]
Dosage:15 mg/kg
Administration:Oral dministration; every 2nd and 3rd day; total 12 times
Result:With Doxorubicin (1.8 mg/kg) significantly decreased the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model.
IC 50VEGFR2: 6 nM (IC50); VEGFR3: 4 nM (IC50); PDGFRα: 15 nM (IC50); c-Kit: 1 nM (IC50)
References[1] Steeghs N, et al.Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor.Clin Cancer Res. 2008 Jun 1;14(11):3470-6. DOI:10.1158/1078-0432.CCR-07-5050
[2] [2] Sodani K, et al. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochem Pharmacol. 2014 May 1;89(1):52-61. DOI:10.1016/j.bcp.2014.02.012
Telatinib mesylate Preparation Products And Raw materials
Tag:Telatinib mesylate(332013-26-0) Related Product Information
PDGF R beta protein, human (biotinylated, HEK293, His-AVI) Protein Tyrosine Kinase Compound Library CD117/C-KIT Protein, HUMAN (HEK293, HIS) VEGFR-1 protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI) VEGFR-3/FLT4 Protein, MOUSE (HEK293, HIS) Anti-cancer compound library